ReCor Medical
Medical technology company focused on development, clinical validation, and commercialization of a catheter-based ultrasound renal denervation therapy for treatment of uncontrolled and resistant hypertension. Activities described on the site include randomized sham-controlled clinical trials, real-world registry and post-approval studies, regulatory approvals (FDA, CE, Japan), reimbursement engagement with CMS, investigator-sponsored research and educational support, and device design features intended to protect the renal artery during ultrasound ablation.
Industries
Nr. of Employees
small (1-50)
ReCor Medical
Palo Alto, California, United States, North America
Products
Ultrasound renal denervation catheter system
A catheter-based system designed to deliver circumferential ultrasound energy to renal nerves via the main renal arteries using brief sonication bursts and an integrated coolant circulation system to protect the arterial wall.
Ultrasound renal denervation catheter system
A catheter-based system designed to deliver circumferential ultrasound energy to renal nerves via the main renal arteries using brief sonication bursts and an integrated coolant circulation system to protect the arterial wall.
Services
Investigator-sponsored research funding
Financial and/or material support for investigator-initiated clinical studies with multi-step review and contractual award process.
Educational content and clinician training
Provision of procedural videos, webinars, symposium recordings, and clinical evidence presentations to support clinician education on renal denervation therapy.
Investigator-sponsored research funding
Financial and/or material support for investigator-initiated clinical studies with multi-step review and contractual award process.
Educational content and clinician training
Provision of procedural videos, webinars, symposium recordings, and clinical evidence presentations to support clinician education on renal denervation therapy.
Expertise Areas
- Renal denervation therapy development
- Randomized, sham-controlled clinical trials
- Real-world evidence generation and registry studies
- Regulatory approvals and market access
Key Technologies
- 360-degree intravascular ultrasound energy delivery
- Balloon catheter coolant (hydro-cooling) systems
- Short-duration ultrasound sonication protocols
- Catheter-based endovascular ablation